High-fidelity human chromosome transfer and elimination
The synthesis of human genomes and other gigabase-scale genomes will require new strategies. Here, we realized key steps in our pipeline for building synthetic human chromosomes. We established: (i) the facile transfer of human chromosomes from human cells to mouse embryonic stem cells (assembly cells), where they are haploid, are nonessential, and may be operated on; (ii) the transfer of these human chromosomes from monochromosomal hybrids back into human cells to generate defined, synthetic aneuploidies; and (iii) the elimination of the corresponding endogenous human chromosomes to regenerate diploid cells containing a transferred chromosome. All steps were performed in nontransformed cells without chromothripsis and generated minimal structural variants, insertions, deletions, or single-nucleotide variants.
Authors
- Julian E. Sale (ORCID: https://orcid.org/0000-0002-5031-3780)
- Jakob Birnbaum (ORCID: https://orcid.org/0000-0002-1419-522X)
- Pierre Murat (ORCID: https://orcid.org/0000-0002-3416-3049)
- Kim C. Liu (ORCID: https://orcid.org/0000-0002-8164-2464)
- Gianluca Petris (ORCID: https://orcid.org/0000-0002-2420-6359)
- Linda van Bijsterveldt (ORCID: https://orcid.org/0000-0003-3183-4633)
- Jason W. Chin (ORCID: https://orcid.org/0000-0003-1219-4757)
- Simona Grazioli (ORCID: https://orcid.org/0000-0002-0682-6060)
Institutions
- MRC Laboratory of Molecular Biology (GB)
- Wellcome Sanger Institute (GB)
- Medical Research Council (GB)
Publication Details
- Journal
- Science
- Published
- 2025-12-04
- DOI
- https://doi.org/10.1126/science.adv9797
- Citations
- 1
- Primary Topic
- Pluripotent Stem Cells Research
- Type
- article
- Field-Weighted Citation Impact
- 0.81